Biotechnology Stock

US Biodefense, Inc.

US Biodefense, Inc. designs and develops homeland security and biodefense products. more

Our disclosure and analysis in this Annual Report on Form 10-K contains some forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements since they do not relate strictly to historical or current facts. Such statements may include words such as “anticipate,” “estimate,” ... more

Javelin Pharmaceuticals, Inc

Javelin Pharmaceuticals, Inc. is engaged in the research and development of products for the pain management market. Unless the context otherwise requires, all references in this report to “Javelin”, “Company”, “we”, “us” or “our” include Javelin Pharmaceuticals, Inc., and any ... more

Thermogenesis Corp

Thermogenesis Corporation engages in the development and sale of automated and semi-automated devices used to process, cryopreserve and store therapeutic doses of adult stem cells for treatment of disease and injury. more

Phase Forward, Inc

Our InForm , Clintrial and Clintrace software solutions are generally provided to our customers for enterprise adoption through multi-year term licenses of generally three to five years with periodic fees. Our WebVDME, CTSD and WebSDM software solutions are generally provided to our customers through annual licenses or multi-year term licenses of two to three years. We also offer ... more

Spectrum Pharm

We are a biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options. Our expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the ... more

Digene Corp

We develop, manufacture and market our proprietary gene-based diagnostic tests for the screening, monitoring and diagnosis of human diseases. Our primary focus is in women’s cancers and infectious diseases. We have applied our proprietary Hybrid Capture ® technology to develop a successful diagnostic test for human papillomavirus (HPV), which is the ... more

Renovis, Inc

Renovis is a science-driven, biopharmaceutical company that seeks to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases. We apply our integrated capabilities in preclinical research and development, including molecular biology, medicinal chemistry, in vitro and in vivo pharmacology, drug metabolism and ... more

Santarus, Inc

We are a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians. The primary focus of our current efforts is the commercialization of proprietary immediate-release proton pump inhibitor, or PPI, products. PPI products are ... more

Impav Labs, Inc

Impax Laboratories, Inc. ("we," "us," "our," "the Company" or "IMPAX") is a specialty pharmaceutical company focused on the development and commercialization of specialty generic and branded pharmaceuticals, utilizing our in-house development and formulation expertise. In the specialty generic pharmaceuticals market, we are focusing our efforts on selected controlled-release generic versions ... more

Biocryst Pharm, Inc

This report includes forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives or assumptions of future events or performance are contained or incorporated by reference in this report. We have based these forward-looking statements on our current expectations about future events. While we believe these expectations ... more

Kv Pharmaceutical Co.

We are a fully integrated specialty pharmaceutical company that develops, acquires, manufactures and markets technologically distinguished branded and generic/non-branded prescription pharmaceutical products. We have a broad range of dosage form capabilities including tablets, capsules, creams, liquids and ointments. We conduct our branded ... more

Ness Technologies, Inc

You also may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 450 Fifth Street, NW, Washington, DC, 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other ... more

Cell Therapeutics, Inc

We develop, acquire and commercialize novel treatments for cancer. Our goal is to build a leading biopharmaceutical company with a diversified portfolio of proprietary oncology drugs. Our research, development, acquisition and in-licensing activities concentrate on identifying and developing new, less toxic and more effective ways to treat cancer. more

Alexandria Real Estate Equities, Inc.

We are a Maryland corporation formed in October 1994 that has elected to be taxed as a real estate investment trust ("REIT") for federal income tax purposes. We are engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry. Our properties are designed and improved for lease primarily to ... more